Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa

Overview

Journal JAAD Case Rep

Specialty Dermatology

Date 2023 Jun 19

PMID 37332363

Authors

Elena Gonzalez Brant

Oleg Akilov

Affiliations

Soon will be listed here.

References

Kimball A, Okun M, Williams D, Gottlieb A, Papp K, Zouboulis C . Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. N Engl J Med. 2016; 375(5):422-34. DOI: 10.1056/NEJMoa1504370. View

Schlapbach C, Hanni T, Yawalkar N, Hunger R . Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011; 65(4):790-798. DOI: 10.1016/j.jaad.2010.07.010. View

Rainsford K, Parke A, Clifford-Rashotte M, Kean W . Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology. 2015; 23(5):231-69. DOI: 10.1007/s10787-015-0239-y. View

Matusiak L, Szczech J, Bieniek A, Nowicka-Suszko D, Szepietowski J . Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents. J Am Acad Dermatol. 2017; 76(4):670-675. DOI: 10.1016/j.jaad.2016.10.042. View

Fischer A, Haskin A, A Okoye G . Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2016; 76(2):309-313.e2. DOI: 10.1016/j.jaad.2016.08.001. View

von der Werth J, Jemec G . Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001; 144(4):809-13. DOI: 10.1046/j.1365-2133.2001.04137.x. View

Hage M, Al-Badri M, Azar S . A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role. Ther Adv Endocrinol Metab. 2014; 5(4):77-85. PMC: 4206615. DOI: 10.1177/2042018814547204. View

Nicola W, Khayria M, Osfor M . Plasma testosterone level and the male genital system after chloroquine therapy. Boll Chim Farm. 1997; 136(1):39-43. View

Sharma T, Wasko M, Tang X, Vedamurthy D, Yan X, Cote J . Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients. J Am Heart Assoc. 2016; 5(1). PMC: 4859400. DOI: 10.1161/JAHA.115.002867. View

10.

Gonzalez-Lopez M, Hernandez J, Lacalle M, Mata C, Lopez-Escobar M, Lopez-Mejias R . Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2016; 75(2):329-35. DOI: 10.1016/j.jaad.2016.03.025. View

11.

van der Zee H, De Ruiter L, van den Broecke D, Dik W, Laman J, Prens E . Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011; 164(6):1292-8. DOI: 10.1111/j.1365-2133.2011.10254.x. View

12.

da Silva J, Mariz H, da Rocha Jr L, Oliveira P, Dantas A, Duarte A . Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (Sao Paulo). 2013; 68(6):766-71. PMC: 3674253. DOI: 10.6061/clinics/2013(06)07. View

13.

Garg A, Lavian J, Lin G, Strunk A, Alloo A . Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017; 77(1):118-122. DOI: 10.1016/j.jaad.2017.02.005. View

14.

Kjaersgaard Andersen R, Jemec G . Treatments for hidradenitis suppurativa. Clin Dermatol. 2017; 35(2):218-224. DOI: 10.1016/j.clindermatol.2016.10.018. View

15.

van den Borne B, Dijkmans B, de Rooij H, le Cessie S, Verweij C . Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol. 1997; 24(1):55-60. View